quinazolines has been researched along with Dilatation, Pathologic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furubo, S; Harada, K; Isse, K; Kizawa, K; Nakanuma, Y; Ozaki, S; Sanzen, T; Sasaki, M; Sato, Y; Yasoshima, M | 1 |
1 other study(ies) available for quinazolines and Dilatation, Pathologic
| Article | Year |
|---|---|
Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.
Topics: Animals; Bile Ducts, Intrahepatic; Dilatation, Pathologic; Disease Models, Animal; ErbB Receptors; Gefitinib; Liver; Liver Diseases; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Polycystic Kidney Diseases; Protein Kinase Inhibitors; Quinazolines; Rats | 2006 |